Dianyun Ren

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Top Venues

Science advances

The EMBO journal

Cancer research

Cellular oncology (Dordrecht)

This page only lists publications with an associated author ORCID identifier.

Publications

Jian Ma, Dianyun Ren, Zixi Wang, Wei Li, Lei Li, Tianjie Liu, Qi Ye, Yuzeshi Lei, Yanlin Jian, Bohan Ma, Yizeng Fan, Jing Liu, Yang Gao, Xin Jin, Zhenlin Huang, Lei Li
CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity. Science advances 10 (21) (2024)
Jian Ma, Dianyun Ren, Zixi Wang, Wei Li, Lei Li, Tianjie Liu, Qi Ye, Yuzeshi Lei, Yanlin Jian, Bohan Ma, Yizeng Fan, Jing Liu, Yang Gao, Xin Jin, Zhenlin Huang, Lei Li
CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity. Science advances 10 (21) (2024)
Jian Ma, Dianyun Ren, Zixi Wang, Wei Li, Lei Li, Tianjie Liu, Qi Ye, Yuzeshi Lei, Yanlin Jian, Bohan Ma, Yizeng Fan, Jing Liu, Yang Gao, Xin Jin, Zhenlin Huang, Lei Li
CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity. Science advances 10 (21) (2024)
Yan Sun, Xin Jin, Junpeng Meng, Feng Guo, Taoyu Chen, Xiaoyan Zhao, Heshui Wu, Dianyun Ren
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression. The EMBO journal (2023)
Junpeng Meng, Hongkun Cai, Yan Sun, Shuang Wen, Heshui Wu, Dianyun Ren
ITGA2 induces STING expression in pancreatic cancer by inducing DNMT1 degradation. Cellular oncology (Dordrecht) (2022)
Wei Wu, Zhenhao Zhang, Doudou Jing, Xin Huang, Dianyun Ren, Zengwu Shao, Zhicai Zhang
SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma. Cell death & disease 13 (6) (2022)
Penglin Pan, Gengdu Qin, Bo Wang, Haixin Yu, Jie Chen, Jiaying Liu, Kaijian Bing, Jian Shen, Dianyun Ren, Yuhan Zhao, Wentao Xia, Hui Li, Heshui Wu, Yingke Zhou
HDAC5 loss enhances phospholipid-derived arachidonic acid generation and confers sensitivity to cPLA2 inhibition in pancreatic cancer. Cancer research (2022)